GetTopicDetailResponse(id=cda411e019f0, topicName=聚乙二醇洛塞那肽, introduction=, content=糖尿病腎病 聚乙二醇洛塞那肽, image=null, comments=0, allHits=852, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Tue Jul 23 14:08:05 CST 2024, time=2024-07-23, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=121080, tagList=[TagDto(tagId=121080, tagName=聚乙二醇洛塞那肽)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2261552, encodeId=9937226155286, content=<a href='/topic/show?id=31618386e18' target=_blank style='color:#2F92EE;'>#胰島素#</a> <a href='/topic/show?id=cda411e019f0' target=_blank style='color:#2F92EE;'>#聚乙二醇洛塞那肽#</a>, objectTitle=真實世界研究證實聚乙二醇洛塞那肽聯(lián)合基礎(chǔ)胰島素可優(yōu)化降糖且兼具減重獲益, objectType=article, longId=872941, objectId=cff18e29414a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241127/1732690455066_8538692.jpg, objectUrl=/article/show_article.do?id=cff18e29414a, replyNumber=0, likeNumber=0, createdTime=2025-04-22, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cff18e29414a, moduleTitle=真實世界研究證實聚乙二醇洛塞那肽聯(lián)合基礎(chǔ)胰島素可優(yōu)化降糖且兼具減重獲益, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=cff18e29414a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2216457, encodeId=dfad221645e0c, content=<a href='/topic/show?id=b081e6760b8' target=_blank style='color:#2F92EE;'>#糖尿病腎病#</a> <a href='/topic/show?id=cda411e019f0' target=_blank style='color:#2F92EE;'>#聚乙二醇洛塞那肽#</a>, objectTitle=聚乙二醇洛塞那肽治療糖尿病腎病患者的首個RCT證據(jù)發(fā)布！療效與達(dá)格列凈相當(dāng)，且改善脂質(zhì)水平更具優(yōu)勢, objectType=article, longId=835562, objectId=c06283556224, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240719/1721357882520_8538692.png, objectUrl=/article/show_article.do?id=c06283556224, replyNumber=0, likeNumber=147, createdTime=2024-07-23, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c06283556224, moduleTitle=聚乙二醇洛塞那肽治療糖尿病腎病患者的首個RCT證據(jù)發(fā)布！療效與達(dá)格列凈相當(dāng)，且改善脂質(zhì)水平更具優(yōu)勢, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c06283556224)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-07-23發(fā)表于上海
